Medicinal Products

Aripiprazol Pliva 30 mg tablete

Name Aripiprazol Pliva 30 mg tablete
Marketing Authorisation Number HR-H-654548929
Active Substance aripiprazol
Composition svaka tableta sadrži 30 mg aripiprazola
Pharmaceutical Form tableta
Manufacturer Merckle GmbH, Blaubeuren, Njemačka
Teva Pharma B.V., Haarlem, Nizozemska
Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Teva Operations Poland Sp. z o.o., Krakow, Poljska
PharmaPath S.A., Agia, Varvara, Grčka
Actavis Limited, Zejtun, Malta
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date 08.05.2019
MA Period of Validity unlimited
Classification Number UP/I-530-09/19-02/07
Registration Number 381-12-01/30-19-03
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N05AX12
Marketing status stavljeno u promet
Shortage status nema nestašice
SmPC download
PL download
Public Assessment Report download

Packaging

Back